CKAP4 and Cognitive impairment: Additionally, decreased CKAP4 may contribute to neuroinflammation, increased neuronal vulnerability, and impaired synaptic plasticity, all of which could exacerbate the neurological and cognitive impairments observed in DM1 patients.